JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5426
Corvus Pharmaceuticals
CRVS
$919M
| $131K | ﹤0.01% |
24,455
-25,101
| -51% | -$187K |
2021 Q4
12 quarters
|
|
|
ABX
5427
Abacus Global Management
ABX
$804M
| $131K | ﹤0.01% |
16,670
+14,420
| +641% | +$124K |
2024 Q3
1 quarter
|
|
5428
Valhi
VHI
$429M
| $130K | ﹤0.01% |
5,565
+4,086
| +276% | +$121K |
2016 Q4
32 quarters
|
|
5429
ProShares Ultra Russell2000
UWM
$224M
| $130K | ﹤0.01% |
3,100
-2,100
| -40% | -$95K |
2023 Q2
6 quarters
|
|
5430
iShares International Developed Small Cap Value Factor ETF
ISVL
$330M
| $129K | ﹤0.01% |
3,768
+2,807
| +292% | +$101K |
2023 Q4
4 quarters
|
|
|
NEXN
5431
Nexxen International
NEXN
$497M
| $129K | ﹤0.01% |
12,885
-45,113
| -78% | -$399K |
2021 Q2
14 quarters
|
|
|
OCTM
5432
FT Vest U.S. Equity Max Buffer ETF - October
OCTM
$31.6M
| $128K | ﹤0.01% |
+4,210
| New | +$128K |
2024 Q4
0 quarters
|
|
5433
Groupon
GRPN
$768M
| $128K | ﹤0.01% |
10,559
-128,377
| -92% | -$1.35M |
2023 Q4
4 quarters
|
|
|
RAPP
5434
Rapport Therapeutics
RAPP
$1.55B
| $127K | ﹤0.01% |
7,170
+3,137
| +78% | +$69.5K |
2024 Q3
1 quarter
|
|
5435
El Paso Energy Capital Trust I
EP.PRC
$218M
| $127K | ﹤0.01% |
2,647
+1,183
| +81% | +$57K |
2024 Q1
3 quarters
|
|
5436
Heritage Insurance Holdings
HRTG
$1.01B
| $127K | ﹤0.01% |
10,473
-148,532
| -93% | -$1.71M |
2017 Q2
30 quarters
|
|
5437
Aldeyra Therapeutics
ALDX
$71.8M
| $127K | ﹤0.01% |
25,394
+1,578
| +7% | +$8.1K |
2017 Q4
28 quarters
|
|
5438
CALL
SentinelOne
S
$8.84B
| $127K | ﹤0.01% |
5,700
-158,600
| -97% | -$4.05M |
2024 Q3
1 quarter
|
|
5439
DNP Select Income Fund
DNP
$3.65B
| $127K | ﹤0.01% |
14,344
+4,397
| +44% | +$41.4K |
2022 Q4
8 quarters
|
|
5440
Southland Holdings
SLND
$36.3M
| $126K | ﹤0.01% |
38,885
+19,694
| +103% | +$65.5K |
2023 Q2
6 quarters
|
|
5441
YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG
$298M
| $126K | ﹤0.01% |
+6,553
| New | +$127K |
2024 Q4
0 quarters
|
|
5442
ATAC Credit Rotation ETF
JOJO
$4.72M
| $126K | ﹤0.01% |
8,540
-1,400
| -14% | -$20.4K |
2023 Q3
5 quarters
|
|
|
SMLR
5443
DELISTED
Semler Scientific
SMLR
| $125K | ﹤0.01% |
2,324
+142
| +7% | +$6.52K |
2023 Q1
7 quarters
|
|
5444
Solidion Technology
STI
$47.8M
| $125K | ﹤0.01% |
3,589
+3,340
| +1,341% | +$69.4K |
2024 Q1
3 quarters
|
|
5445
CALL
Consolidated Edison
ED
$38.2B
| $125K | ﹤0.01% |
+1,400
| New | +$138K |
2024 Q4
0 quarters
|
|
5446
CALL
Abbott
ABT
$168B
| $124K | ﹤0.01% |
1,100
+900
| +450% | +$104K |
2023 Q4
4 quarters
|
|
5447
CALL
Digital Realty Trust
DLR
$66B
| $124K | ﹤0.01% |
700
+200
| +40% | +$35.5K |
2024 Q1
3 quarters
|
|
|
CMA
5448
CALL
DELISTED
Comerica
CMA
| $124K | ﹤0.01% |
+2,000
| New | +$130K |
2024 Q4
0 quarters
|
|
|
CMA
5449
PUT
DELISTED
Comerica
CMA
| $124K | ﹤0.01% |
+2,000
| New | +$130K |
2024 Q4
0 quarters
|
|
5450
Dimensional Inflation-Protected Securities ETF
DFIP
$1.1B
| $123K | ﹤0.01% |
3,034
-297
| -9% | -$12.3K |
2023 Q3
5 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.